Last updated on November 2017

Children and Adolescents with Bipolar I Disorder


Brief description of study

Children and Adolescents with Bipolar I Disorder

Detailed Study Description

A phase 3, multicenter, four-week, randomized, double-blind, placebo-controlled study to evaluate safety and efficacy in children and adolescents with Bipolar I Disorder

Clinical Study Identifier: TX3823

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Ashley Nalley

Atlanta Center for Medical Research
Atlanta, GA USA
  Connect »